Martin L. Seidel is a partner in Willkie’s Litigation Department. He has more than 25 years’ experience in securities and corporate litigation and arbitration, with an emphasis on corporate control contests, transaction-related securities and shareholder litigations, multiparty class actions and derivative litigations. He regularly advises on litigation matters related to mergers and acquisitions, securities laws, corporate accounting and disclosure, and corporate governance.

Mr. Seidel has tried cases before state and federal courts throughout the United States as well as arbitral tribunals. He has handled investigations before the U.S. Securities and Exchange Commission, FINRA, the U.S. Department of Justice and the U.S. Federal Trade Commission, and by state and federal prosecutors and state Attorneys General across the country.

Mr. Seidel provides clients – including Fortune 500 companies, leading financial institutions, corporate boards, directors and senior executives – with guidance on:

M&A, corporate control and activism-related litigation
corporate control and corporate governance issues
complex securities, shareholder and derivative litigations
insider trading, market manipulation and accounting fraud litigations and investigations

He has advised key players in numerous high-profile matters, including takeover litigation and defense for Salix Pharmaceuticals, Élan Corporation, Pfizer, Jos. A Bank and Quest Software; and litigations and investigations involving Hollinger, HealthSouth, Bear Stearns, Adelphia and Refco/SphinX.

Mr. Seidel is recognized as a leading securities litigator by Legal 500 U.S. and Super Lawyers. Mr. Seidel is a published author and frequent speaker on matters of corporate governance, securities litigation, directors and officers insurance, and complex litigation.